In the last 7 days
BMS’s Opdivo meets co-primary endpoint in colorectal cancer trial Clinical Trials Arena12:26 8-Dec-23
Bristol Myers Squibb bids farewell to dealmaking czar Elizabeth Mily FiercePharma11:48 8-Dec-23
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer BioSpace07:40 8-Dec-23
BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer PMLiVE07:28 8-Dec-23
Insiders Buying Bristol-Myers Squibb And 3 Other Stocks Benzinga07:16 8-Dec-23
Top Bristol Myers Squibb Dealmaker Elizabeth Mily Is Leaving Bloomberg Law15:15 7-Dec-23
Global Tyrosine Kinase Inhibitors Market Report 2023-2028, Featuring Profiles of Major Players… PR Newswire (Press Release)14:15 7-Dec-23
Why Bristol Myers Squibb's Shares Are Gaining Today? Benzinga12:46 7-Dec-23
Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) BioSpace12:41 7-Dec-23
Daily Dividend Report: BMY,PM,AXP,MO,EMN Nasdaq12:27 7-Dec-23
Nivolumab Plus Ipilimumab Improves PFS in Newly Diagnosed Metastatic Colorectal Cancer OncLive11:43 7-Dec-23
After 5.3% Dividend Boost, Bristol-Myers (NYSE:BMY) Expands Share Buyback to $5B TipRanks08:57 7-Dec-23
IN8bio Appoints Dr. Corinne Epperly to Board of Directors GlobeNewswire (Press Release)08:11 7-Dec-23
Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization Business Wire (Press Release)06:35 7-Dec-23
Japan approves BMS’ Abecma for multiple myeloma treatment Pharmaceutical Technology05:45 7-Dec-23
Bristol Myers Squibb raises dividend by 5.3% MarketWatch17:23 6-Dec-23
Bristol Myers Squibb Raises Dividend 5.3%, to 60 Cents MarketWatch16:42 6-Dec-23
Bristol Myers Squibb Announces Dividend Increase Business Wire (Press Release)16:21 6-Dec-23
FDA Accepts Priority Review of BMS Opdivo, Chemo in Bladder Cancer Race BioSpace11:35 6-Dec-23
IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated… Business Wire (Press Release)08:32 6-Dec-23
Metastatic Prostate Cancer Market to Grow Significantly by 2032 | AstraZeneca, Arvinas, Madison … Industry Today08:27 6-Dec-23
FDA accepts Bristol Myers Squibb sBLA for urothelial carcinoma therapy Pharmaceutical Technology03:44 6-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Primary CNS Lymphoma: Likelihood of… Pharmaceutical Technology21:48 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Extranodal Marginal Zone B-Cell Lymphoma… Pharmaceutical Technology20:47 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Nodal Marginal Zone B-Cell Lymphoma:… Pharmaceutical Technology20:47 5-Dec-23
Ipilimumab by Bristol-Myers Squibb for Soft Tissue Sarcoma: Likelihood of Approval Pharmaceutical Technology12:58 5-Dec-23
Ipilimumab by Bristol-Myers Squibb for Melanoma: Likelihood of Approval Pharmaceutical Technology12:58 5-Dec-23
BMS chases MSD/Seagen with first-line bladder cancer filing pharmaphorum12:17 5-Dec-23
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) BioSpace10:41 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Marginal Zone B-cell Lymphoma: Likelihood… Pharmaceutical Technology00:02 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Refractory Chronic Lymphocytic Leukemia… Pharmaceutical Technology00:02 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Relapsed Chronic Lymphocytic Leukemia… Pharmaceutical Technology00:02 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Secondary CNS Lymphoma: Likelihood of… Pharmaceutical Technology00:02 5-Dec-23
Lisocabtagene maraleucel by Bristol-Myers Squibb for Mantle Cell Lymphoma: Likelihood of… Pharmaceutical Technology00:02 5-Dec-23
BMS-986360 by Bristol-Myers Squibb for Triple-Negative Breast Cancer (TNBC): Likelihood of… Pharmaceutical Technology12:19 4-Dec-23
Cabiralizumab by Bristol-Myers Squibb for Melanoma: Likelihood of Approval Pharmaceutical Technology12:19 4-Dec-23
Ipilimumab by Bristol-Myers Squibb for Metastatic Adenocarcinoma of The Pancreas: Likelihood of … Pharmaceutical Technology11:59 4-Dec-23
Ipilimumab by Bristol-Myers Squibb for Metastatic Transitional (Urothelial) Tract Cancer:… Pharmaceutical Technology11:59 4-Dec-23
In the last month
Top Buys by Top Brass: Chief Executive Officer Boerner's $150K Bet on BMY Nasdaq14:39 1-Dec-23
Avidity and BMS enter $2.3bn deal for cardiovascular targets Pharmaceutical Technology03:45 29-Nov-23
STAT Plus: White House official dings Bristol-Myers Squibb for fighting off generic competition STAT20:48 28-Nov-23
FDA Launches Probe of Malignancies Linked to CAR-T Therapies BioSpace18:26 28-Nov-23
BMS Expands Cardio Partnership with Avidity in Potential $2.3B Deal BioSpace11:08 28-Nov-23
Bristol-Myers (NYSE:BMY) Expands Collaboration with Avidity Bio in $2.3B Deal TipRanks09:58 28-Nov-23
Avidity Biosciences leaps on Bristol-Myers research tie-up Proactive Investors (US)07:41 28-Nov-23
Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better Seeking Alpha07:11 28-Nov-23
Bristol Myers Squibb to Take Stake in Avidity Biosciences, Expand Partnership MarketWatch07:00 28-Nov-23
Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers… PR Newswire (Press Release)06:31 28-Nov-23
Poisoning Treatment Market Projected to Show Strong Growth| BTG, Novartis, Bristol-Myers Squibb Industry Today05:06 28-Nov-23
Bristol Myers Squibb Named Top Dividend Stock With Insider Buying and 4.58% Yield (BMY) Nasdaq16:59 27-Nov-23
Bristol-Myers Squibb Unusual Options Activity Benzinga15:48 27-Nov-23
Minnesota Patent Litigation Wrap-Up: Q3 2023 JD Supra13:27 27-Nov-23
Bristol-Myers Squibb sees highest patent filings and grants during August in Q3 2023 Pharmaceutical Technology07:55 24-Nov-23
Biotech Stock Roundup: BMY, TSVT Down on Setback, TRDA, MOR Offer Updates Zacks09:05 23-Nov-23
Bristol-Myers Squibb: The Patent Expiry Challenge Seeking Alpha03:40 23-Nov-23
Bristol Myers Squibb: A Bitter Pill But Still A Buy Seeking Alpha13:00 22-Nov-23
Bristol-Myers Squibb: A Tough But Cheap Spot Seeking Alpha13:36 21-Nov-23
STAT Plus: Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to… STAT12:55 21-Nov-23
Midday Movers: Boeing and GM Advance, Bristol-Myers Squibb Declines Investopedia12:15 21-Nov-23
Bristol Myers (BMY), TSVT Cell Therapy Abecma Faces Setback Zacks09:34 21-Nov-23
FDA delays decision on Bristol-Myers Squibb, 2seventy bio cancer drug Biopharma Reporter08:38 21-Nov-23
FDA delays assessment of BMS and 2seventy’s CAR-T therapy Pharmaceutical Technology08:33 21-Nov-23
FDA Delays Decision on BMS, 2seventy bio’s Push for Earlier Line Abecma Treat... BioSpace07:40 21-Nov-23
Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug Investopedia16:45 20-Nov-23
Notable Monday Option Activity: BMY, KRTX, HUN Nasdaq15:53 20-Nov-23
Why Bristol Myers Squibb Stock Is Fading Today The Motley Fool11:51 20-Nov-23
Bristol Myers Squibb (NYSE:BMY) Falls after FDA Delays Action on Cancer Therapy TipRanks10:24 20-Nov-23
Bristol Myers Squibb Stock Falls After Drug Approval Delayed Barron's Online09:49 20-Nov-23
Bristol Myers Squibb slumps as FDA convenes advisory panel for drug application Investing.com09:39 20-Nov-23
Thinking about trading options or stock in Meta Platforms, Johnson & Johnson, PENN… PR Newswire (Press Release)09:38 20-Nov-23
M&As: what’s up with the ADC buying spree? Labiotech09:10 20-Nov-23
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment MarketWatch08:43 20-Nov-23
Microsoft, Nvidia, Boeing rise premarket; Uber, Nikola fall Investing.com08:03 20-Nov-23
Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in… BioSpace07:25 20-Nov-23
Lifesciences giant BMS pharma could create 300 jobs – if it gets green light for Dublin plant… The Irish Independent08:00 19-Nov-23
Risk adjusted net present value: What is the current valuation of Bristol-Myers Squibb’s… Pharmaceutical Technology22:30 18-Nov-23
Trotabresib by Bristol-Myers Squibb for Follicular Lymphoma: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23
Trotabresib by Bristol-Myers Squibb for Diffuse Large B-Cell Lymphoma: Likelihood of Approval Pharmaceutical Technology14:22 18-Nov-23
Trotabresib by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval Pharmaceutical Technology12:51 18-Nov-23
BBP-398 by Bristol-Myers Squibb for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval Pharmaceutical Technology22:15 17-Nov-23
BBP-398 by Bristol-Myers Squibb for Colorectal Cancer: Likelihood of Approval Pharmaceutical Technology22:15 17-Nov-23
BBP-398 by Bristol-Myers Squibb for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of… Pharmaceutical Technology22:15 17-Nov-23
Nivolumab by Bristol-Myers Squibb for Metastatic Biliary Tract Cancer: Likelihood of Approval Pharmaceutical Technology21:23 17-Nov-23
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity Benzinga13:43 17-Nov-23
Bristol Myers Squibb: Bright Future Ahead Seeking Alpha04:53 17-Nov-23
Nivolumab by Bristol-Myers Squibb for Nasopharyngeal Cancer: Likelihood of Approval Pharmaceutical Technology22:46 16-Nov-23
Bristol Myers Squibb shares dip as market shows mixed results Investing.com20:27 16-Nov-23
National Grid Renewables Announces Power Purchase Agreements with Fujifilm and Bristol Myers… PR Newswire (Press Release)18:05 16-Nov-23
Augtyro US FDA-approved for ROS1+ non-small-cell lung cancer BioWorld14:40 16-Nov-23
BMS Drug Augtyro Gets FDA Approval to Treat ROS1-Positive NSCLC BioSpace11:24 16-Nov-23
Blood Preparation Market Size, Share & Trends Analysis Report 2023- Global Forecast to 2030 Featuring Pfizer,… GlobeNewswire (Press Release)07:36 16-Nov-23
Bristol Myers Squibb's lung cancer drug Augtyro receives FDA approval PMLiVE07:32 16-Nov-23
Bristol Myers Squibb scores FDA approval for lung cancer drug from Turning Point buyout ENDPOINTS07:14 16-Nov-23
Could Bristol-Myers Squibb Stock Help You Retire A Millionaire? The Motley Fool06:05 16-Nov-23
BMS gets US approval for ROS1 lung cancer drug Augtyro pharmaphorum05:47 16-Nov-23
FDA approves BMS’s Augtyro for lung cancer treatment Pharmafile05:43 16-Nov-23
Fujifilm, Bristol Myers Squibb clinch PPAs for Texas solar power RenewablesNow.com01:31 16-Nov-23
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), … BioSpace22:51 15-Nov-23
BMS Grows Its Lung Cancer Portfolio With ‘Best-In-Class’ Augtyro Approval Scrip Pharma Intelligence22:02 15-Nov-23
Nanomaterials in Personalized Medicine Global Markets Report 2023-2028 with Profiles and… PR Newswire (Press Release)19:00 15-Nov-23
National Grid Renewables secures PPAs to build 270-MW solar project Solar Power World14:40 15-Nov-23
Fujifilm and Bristol Myers Squibb Sign Power Purchase Agreements with National Grid Renewables PR Newswire (Press Release)13:00 15-Nov-23
Hypertrophic Cardiomyopathy Treatment Market to Exhibit Impressive Growth by 2023, Predicts DelveInsight | Key… GlobeNewswire (Press Release)13:02 14-Nov-23
BMS looks to expand biologics plant in Ireland BioProcess Insider12:09 14-Nov-23
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment The Motley Fool10:10 14-Nov-23
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress Business Wire (Press Release)07:03 14-Nov-23
February 2024 Options Now Available For Bristol Myers Squibb (BMY) Nasdaq11:12 13-Nov-23
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win? The Motley Fool07:28 11-Nov-23
Bristol Myers Squibb’s CAR-T Breyanzi wins FDA priority review Pharmaceutical Technology09:35 10-Nov-23
Is Bristol Myers Squibb Stock Undervalued At $50? Forbes08:03 10-Nov-23
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? Benzinga23:18 9-Nov-23
Bristol Myers Squibb to Participate in the 2023 Jefferies London Healthcare Conference Business Wire (Press Release)16:20 9-Nov-23

      
            
      
    view more headlines
   
      
      
      
8 Dec 12:26
   
Bristol Myers Squibb News

NewsNow brings you the latest news from the world’s most trusted sources on Bristol Myers Squibb. NewsNow aims to be the world’s most accurate and comprehensive Bristol Myers Squibb news aggregator, bringing you the latest headlines automatically and continuously 24/7.
Bristol Myers Squibb

Latest News

Bristol Myers Squibb News

Pharmaceuticals Top Stories

Business Top Stories
